MicrobeWorld

A component of a potential vaccine opens to rearrange proteins and to possibly reveal new targets to prevent HIV infection and AIDS. An international team of researchers from the U.S., Sweden, and France studied the structure and behavior of the HIV envelope protein complex, which could serve as a component of a vaccine that encourages the human immune system to generate antibodies against HIV.